Jonathan P. DiVincenzo - 24 Oct 2026 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Oct 2026, 16:57:11 UTC
Prior SEC filing
09 Sep 2026
Next SEC filing
12 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan P. DiVincenzo
Filing notes and source

Key filing fact

Jonathan P. DiVincenzo filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 27 Oct 2026.

Key facts

  • This page summarizes Jonathan P. DiVincenzo's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:57.

Change

  • Previous filing in this sequence was filed on 09 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001453524 Primary reporting owner

DiVincenzo Jonathan P.

Relationship
President & COO
Address
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES
Signature
/s/ Jonathan P. DiVincenzo
Signature date
25 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value
Shares
+1,869
Change %
+95%
Price
$0.000000*
Shares after
3,832
Date
24 Oct 2026
Ownership
Direct
Footnotes
F1
BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value
Shares
-951
Change %
-25%
Price
$369.95*
Shares after
2,881
Date
24 Oct 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,869
Change %
-33%
Price
$0.000000*
Shares after
3,740
Date
24 Oct 2026
Ownership
Direct
Underlying class
Bio-Rad A Common Stock
Underlying amount
1,869
Exercise price
$0.000000
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F3

The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .